PremiumRatingsCautious Hold Rating for Treace Medical Concepts Amid Mixed Outlook and Revenue Uncertainty Treace Medical Concepts Reports Q1 2025 Financial Results Treace Medical reports Q1 EPS (25c), consensus (30c) PremiumCompany AnnouncementsTreace Medical Concepts CEO to Become Board Chairman Treace Medical appoints John Treace as chairman of the board Treace Medical price target lowered to $9.50 from $10 at Truist PremiumThe FlyTreace Medical upgraded to Buy from Neutral at BTIG Treace Medical announces completion of first cases using SpeedAkin ACI Treace Medical ‘a rarer asset’ after Zimmer buys Paragon 28, says Lake Street 
